The quality of life and the sexual activity of prostate cancer patients after radical radiotherapy in comparison with group without cancer
Journal Title: OncoReview - Year 2013, Vol 3, Issue 1
Abstract
[b]Background:[/b] Prostate cancer is a disease with a significant impact on quality of life (QoL) both during and after cancer treatment.[b]The aim of study[/b]: The aim of this study was assessment of QoL and sexual activity of prostate cancer survivors after radiotherapy in comparison with the healthy men.[b]Material and methods[/b]: 100 men were included to the study: 50 non-metastatic prostate cancer patients (54–83 years, median 69 years) after radical radiotherapy treatment (8–71 months; mean 27.5 months) and 50 healthy men (55–84 years, median 69 years). Subjects filled out a questionnaires that included EORTC QLQ.C-30 (version 3.0.), EORTC PR-25 and additional demographic and medical questionnaires.[b]Results[/b]: Three and more months after prostate cancer treatment patients estimated their QoL on the same level as healthy subjects. The symptoms from genitourinary and gastrointestinal tracts did not impact on QoL. There were no significant differences in physical functioning, role functioning, emotional functioning, as well as in cognitive and social functioning. There were differences between too groups in sexual activity, erection and sexual satisfaction.[b]Conclusions:[/b] Radical radiotherapy of prostate cancer patients does not impact on QoL and general health status. Some differences were observed in sexual activity, but it could also depend on additional hormonal treatment.
Authors and Affiliations
Monika Rucińska, Anna Kieszkowska-Grudny, Katarzyna Klimowicz , Sergiusz Nawrocki
Keywords
Related Articles
- EP ID EP53199
- DOI -
- Views 243
- Downloads 0
“Life-saving” inappropriate implantable cardioverter-defibrillator shocks in a cancer patient
Impaired left ventricular ejection fraction (LV EF) in patients with cancer can disqualify them from targeted antineoplastic treatment. We present the case of 63-year-old male with gastric cancer treated palliatively, wi...
Nasopharyngeal carcinoma – treatment possibilities in patients with primary metastatic carcinoma
This article presents methods of effective treatment of primary metastatic nasopharyngeal carcinoma, both causative and symptomatic, taking into account possible available treatment therapies (chemotherapy, targeted ther...
Advanced skin melanoma – systemic treatment
In Poland, morbidity and mortality rates for melanoma are constantly increasing. In the case of inoperable disease or distant metastases, prognosis remains poor. For many years, dacarbazine has been the gold standard in...
Phase 3 Trial of Everolimus for Metastatic Renal Cell Carcinoma Final Results and Analysis of Prognostic Factors
A phase 3 trial demonstrated superiority at interim analysis for everolimus over placebo in patients with metastatic renal cell carcinoma (mRCC) progressing on vascular endothelial growth factor receptor tyrosine kinase...
Rola i miejsce jakości życia w nowoczesnym leczeniu chorych na raka płuca
Jakość życia to osobisty sposób postrzegania przez jednostkę pozycji zajmowanej w życiu w kontekście kultury i systemu wartości oraz w odniesieniu do stawianych sobie celów, oczekiwań i obaw. Chorzy zmieniają postrzegani...